Search Page

1

Cite

Share

Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors.

Basu S, Parghane RV, Kamaldeep, Chakrabarty S. Basu S, et al. Among authors: parghane rv. Semin Nucl Med. 2020 Sep;50(5):447-464. doi: 10.1053/j.semnuclmed.2020.05.004. Epub 2020 Jul 3. Semin Nucl Med. 2020. PMID: 32768008 Review.

Cite

Share

2

Cite

Share

PET/Computed Tomography and PET/MR Imaging: Basic Principles, Methodology, and Imaging Protocol for Musculoskeletal Applications.

Parghane RV, Basu S. Parghane RV, et al. PET Clin. 2018 Oct;13(4):459-476. doi: 10.1016/j.cpet.2018.05.003. Epub 2018 Aug 17. PET Clin. 2018. PMID: 30219182 Review.

Cite

Share

3

Cite

Share

¹³¹I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy.

Parghane RV, Talole S, Basu S. Parghane RV, et al. Ann Nucl Med. 2021 Jan;35(1):92-101. doi: 10.1007/s12149-020-01541-z. Epub 2020 Nov 1. Ann Nucl Med. 2021. PMID: 33135123

Cite

Share

4

Cite

Share

Towards personalizing treatment strategies in mCRPC: can dual-tracer PET-CT provide insights into tumor biology, guide the optimal treatment sequence, and individualize decision-making (between chemotherapy, second-generation anti-androgens and PSMA-directed radioligand therapy) early in the disease course?

Basu S, Parghane RV, Suman S, Joshi A, Prabhash K, Bakshi G, Banerjee S. Basu S, et al. Among authors: parghane rv. Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1793-1797. doi: 10.1007/s00259-019-04616-w. Eur J Nucl Med Mol Imaging. 2020. PMID: 31776630 No abstract available.

Cite

Share

5

Cite

Share

PET/Computed Tomography in Treatment Response Assessment in Cancer: An Overview with Emphasis on the Evolving Role in Response Evaluation to Immunotherapy and Radiation Therapy.

Parghane RV, Basu S. Parghane RV, et al. PET Clin. 2020 Jan;15(1):101-123. doi: 10.1016/j.cpet.2019.08.005. PET Clin. 2020. PMID: 31735297 Review.

Cite

Share

6

Cite

Share

Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant ¹⁷⁷Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.

Parghane RV, Bhandare M, Chaudhari V, Ostwal V, Ramaswamy A, Talole S, Shrikhande SV, Basu S. Parghane RV, et al. J Nucl Med. 2021 Nov;62(11):1558-1563. doi: 10.2967/jnumed.120.258772. Epub 2021 Feb 26. J Nucl Med. 2021. PMID: 33637590 Free PMC article.

Cite

Share

7

Cite

Share

One decade of 'Bench-to-Bedside' peptide receptor radionuclide therapy with indigenous [¹⁷⁷Lu]Lu-DOTATATE obtained through 'Direct' neutron activation route: lessons learnt including practice evolution in an Indian setting.

Basu S, Chakraborty S, Parghane RV, Kamaldeep, Ranade R, Thapa P, Asopa RV, Sonawane G, Nabar S, Shimpi H, Chandak A, Vimalnath KV, Ostwal V, Ramaswamy A, Bhandare M, Chaudhari V, Shrikhande SV, Sirohi B, Dash A, Banerjee S. Basu S, et al. Among authors: parghane rv. Am J Nucl Med Mol Imaging. 2020 Aug 25;10(4):178-211. eCollection 2020. Am J Nucl Med Mol Imaging. 2020. PMID: 32929396 Free PMC article. Review.

Cite

Share

8

Cite

Share

Dual-time point ¹⁸F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations.

Parghane RV, Basu S. Parghane RV, et al. Semin Nucl Med. 2017 Jul;47(4):373-391. doi: 10.1053/j.semnuclmed.2017.02.009. Epub 2017 Apr 19. Semin Nucl Med. 2017. PMID: 28583277 Review.

Cite

Share

9

Cite

Share

Capecitabine-Temozolomide in Advanced Grade 2 and Grade 3 Neuroendocrine Neoplasms: Benefits of Chemotherapy in Neuroendocrine Neoplasms with Significant 18FDG Uptake.

Ostwal V, Basu S, Bhargava P, Shah M, Parghane RV, Srinivas S, Chaudhari V, Bhandare MS, Shrikhande SV, Ramaswamy A. Ostwal V, et al. Among authors: parghane rv. Neuroendocrinology. 2021;111(10):998-1004. doi: 10.1159/000511987. Epub 2020 Oct 5. Neuroendocrinology. 2021. PMID: 33017827

Cite

Share

10

Cite

Share

Designing and Developing PET-Based Precision Model in Thyroid Carcinoma: The Potential Avenues for a Personalized Clinical Care.

Basu S, Parghane RV. Basu S, et al. Among authors: parghane rv. PET Clin. 2017 Jan;12(1):27-37. doi: 10.1016/j.cpet.2016.08.007. Epub 2016 Sep 23. PET Clin. 2017. PMID: 27863564 Review.

Cite

Share